Skip to main content
. 2019 Sep 13;13(3):391–401. doi: 10.1016/j.jiph.2019.07.018

Table 1.

Progress in capacity strengthening for influenza surveillance in the 22 countries of the WHO Eastern Mediterranean Region between 2011 and 2018.

Indicator 2011 2018 Difference P value
  • A

    Influenza epidemiological surveillance

No. of countries with a functioning influenza surveillance systema 10/22(50%) 19/22 (86.3%) 36.3% 0.0008
No. of countries with more than 1 sentinel site for ILI/SARI 8 19 57.9% 0.0001
No of countries reporting influenza epidemiological data to FluID for <90% of the weeks a year 5/10 (50%) 9/19 (47.38%) 2.62% 0.89
  • B

    Influenza virological surveillance

No. of NICs 13 16 15.79% 0.25
No. of countries reporting influenza virological surveillance data to FluNET for 90% of the weeks a year 9 16 36.84% 0.01
No. of NICs and influenza laboratories with RT-PCR capacity 9/13 (69.2%) 19/19 (100%)b 30.8% 0.01
No. of NICs and influenza laboratories with capacity for influenza virus isolation 9/13 (69.2%) 12/16 (75%) 5.8% 0.73
No. of NICs and other influenza laboratories with sequencing capacity (including testing for antiviral susceptibility) 3/13 (23%) 7/16 (43.7) 20.7% 0.25
No. of NICs and other influenza laboratories participating in WHO EQAP 9/13 (69.2%) 19/19 (100%)b 30.8% 0.01
No. of NICs and other influenza laboratories achieving a 90% efficiency score on WHO EQAP 11/14 (78.5%)c 19/19 (100%)b 21.5% 0.03
  • C

    Burden estimation

No. of countries with influenza surveillance system estimating influenza disease burden using surveillance datad 0/10 (0%) 6/19 (31.57%) 31.57 0.04
  • D

    Use of seasonal influenza vaccines

No. of countries using seasonal influenza vaccines 12/22 (55%) 17/22 (77%) 22% 0.11

SARI: severe acute respiratory illness, NIC: national influenza centre, RT-PCR: real-time polymerase chain reaction,EQAP: external quality assessment programme).

a

measured against all 21 countries and occupied Palestinian territory of the WHO Eastern Mediterranean Region.

b

includes three influenza laboratories which are not designated as NIC as of 2018.

c

includes one influenza laboratory which was not designated as NIC in 2011.

d

out of the countries with influenza surveillance system in 2011 (10) and 2018 (19).